Then, we describe the unique role of IRF4 in acute leukemias and B cell mature neoplasia, focusing on biological mechanisms and possible therapeutic strategies in multiple myeloma (MM) and chronic lymphocytic leukemia (CLL). The gene discussed is IRF4; the disease is AL amyloidosis.